Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases. Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases

Growing evidence suggests an increased prevalence of nonalcoholic fatty liver disease (NAFLD) in the context of immune-mediated inflammatory diseases (IMIDs). We aimed to clinically and mechanistically characterize a prospective cohort of IMID-NAFLD patients compared to classic-NAFLD patients. Overall design: Comparative gene expression analysis of RNA-seq data from freshly frozen liver biopsies of IMID-NAFLD and classic-NAFLD patients.